medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2019, Number 1

<< Back Next >>

Ann Hepatol 2019; 18 (1)

Alcohol and the Liver: The Return of the Prodigal Son

Campollo O

Language: English
References: 16
Page: 6-10
PDF size: 136.34 Kb.


ABSTRACT

With the discovery of direct-acting antivirals and the prospective of viral hepatitis becoming curable, alcohol liver disease (ALD) is back to primetime. In the last 20 years, there have been many advances in the understanding of the biology, the psychology and the social and environmental factors associated with this long-known medical problem. Recent information about regional, ethnic, cultural and genetic factors seem to be relevant for the Latin American (LA) population. New approaches based on the new concepts and current information will render better results in the overall management of patients with this problem. Considering alcohol use disorder and ALD as part of the same entity managing it in a multidisciplinary approach seems to be best way to deal with this disease.


REFERENCES

  1. Webster DP, Klenerman P, Dusheiko G. Lancet seminar-Hepatitis C. Lancet 2015; 385: 1124-35. Doi: 10.1016/S0140- 6736(14)62401-6.

  2. O’Shea RS, Dasarathy S, McCullough AJ, and the Practice Guideline Committee of the American Association for the Study of Liver Diseases and the Practice Parameters Committee of the American College of Gastroenterology. Alcoholic Liver Disease. Hepatology 2010; 51: 307-28.

  3. Singal AK, Anand BS. Recent Trends in the Epidemiology of Alcoholic Liver Disease. Clin Liv Dis 2013; 2: 53-6.

  4. Mendez SN, Almeda VP, Uribe M. Alcoholic liver disease. An update. Ann Hepatology 2005; 4: 32-42.

  5. European Association for the study of the liver. EASL Clinical practice guidelines: Management of alcohol-related liver disease. J Hepatol 2018; 69: 154-181. Accessed 1/11/2018 at https://doi.org/10.1016/j.jhep.2018.03.018

  6. World Health Organization. Global status report on alcohol and health 2018. Geneva: 2018. Accessed the 30/05/2018 at: Global Health Observatory (GHO) data>Global Information System on Alcohol and Health –(GISAH): Harms and consequences

  7. Setiawan VW, Straml DO, Porcel J, Lu SC, Le Marchand L, Noureddin M. Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: the Multiethnic Cohort. Hepatology 2016; 64: 1969-77. Doi:10.1002/hep.28677.

  8. Campollo O, Valencia JJ, Berumen A, Perez MA, Panduro A, Segura J. Epidemiology of liver cirrhosis at the Hospital Civil de Guadalajara. Sal Pub Mex 1997; 39: 195-200.

  9. Mokdad AA, Lopez AD, Shahraz S, Lozano R, Mokdad AH, Stanaway J, Murray JL, et al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Medicine 2014, 12:145 Accessed 31/05/2018 at: http:// www.biomedcentral.com/1741-7015/12/145

  10. Secretaría de Salud. Anuario de morbilidad 1984-2016. Sistema Único de Información para la Vigilancia Epidemiológica/ Dirección General de Epidemiología/SSA, (SINAVE/DGE/ SALUD, SUIVE/DGE). Accessed 16/05/2018 at: https:// www.gob.mx/cms/uploads/attachment/file/267597/ Mortalidad_2010.pdf and http://www.inegi.org.mx/est/contenidos/ proyectos/registros/vitales/mortalidad/tabulados/ ConsultaMortalidad.asp

  11. Liangpunsakul S, Haber P, McCaughan G. Alcoholic Liver Disease in Asia, Europe, and North America. Gastroenterology 2016; 150: 1786-97. Doi: 10.1053/j.gastro.2016.02.043. Epub 2016 Feb 27

  12. Gómez-Dantés H, Castro MV, Franco-Marina F, Bedregal P, Rodríguez-García J, Espinoza A, Valdez-Huarcaya W, et al. La carga de la enfermedad en países de América Latina. Sal Pub Mex 2011; 53(Supl. 2): S72-S77.

  13. Campollo O, Martínez MD, Valencia JJ, Segura J. Drinking patterns and beverage preferences of liver cirrhosis patients in Mexico. Substance use and misuse 2001; 36: 387- 98.

  14. Ramos-Lopez O, Martinez-Lopez E, Roman S, Fierro NA, Panduro A. Genetic, metabolic and environmental factors involved in the development of liver cirrhosis in Mexico. World J Gastroenterol 2015; 21: 11552-66.

  15. Solodun YV, Monakhova YB, Kuballa T, Samokhvalov AV, Rehm J, Lachenmeier DW. Unrecorded alcohol consumption in Russia: toxic denaturants and disinfectants pose additional risks. Interdiscip Toxicol 2011; 4: 198-205.

  16. Tsochatzis EA, Bosch J and Burroughs AK. New therapeutic paradigm for patients with Cirrhosis. Hepatology 2012; 56: 1983-92.




2020     |     www.medigraphic.com